Revolution Medicines, Inc. (RVMD)

Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $14.75 billion. The enterprise value is $12.98 billion.

Market Cap	14.75B
Enterprise Value	12.98B

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

RVMD has 193.32 million shares outstanding. The number of shares has increased by 15.98% in one year.

Current Share Class	193.32M
Shares Outstanding	193.32M
Shares Change (YoY)	+15.98%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	93.40%
Float	173.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.07
P/TBV Ratio	9.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.05, with a Debt / Equity ratio of 0.10.

Current Ratio	8.05
Quick Ratio	7.86
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-84.35

Financial Efficiency

Return on equity (ROE) is -60.76% and return on invested capital (ROIC) is -38.03%.

Return on Equity (ROE)	-60.76%
Return on Assets (ROA)	-32.29%
Return on Invested Capital (ROIC)	-38.03%
Return on Capital Employed (ROCE)	-51.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.80M
Employee Count	534
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-753,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.49% in the last 52 weeks. The beta is 0.99, so RVMD's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+34.49%
50-Day Moving Average	55.09
200-Day Moving Average	42.70
Relative Strength Index (RSI)	86.95
Average Volume (20 Days)	2,501,560

Short Selling Information

The latest short interest is 18.02 million, so 9.32% of the outstanding shares have been sold short.

Short Interest	18.02M
Short Previous Month	19.36M
Short % of Shares Out	9.32%
Short % of Float	10.36%
Short Ratio (days to cover)	8.47

Income Statement

Revenue	n/a
Gross Profit	-880.49M
Operating Income	-1.04B
Pretax Income	-961.73M
Net Income	-960.98M
EBITDA	-1.03B
EBIT	-1.04B
Earnings Per Share (EPS)	-$5.19

Balance Sheet

The company has $1.93 billion in cash and $158.46 million in debt, giving a net cash position of $1.77 billion or $9.17 per share.

Cash & Cash Equivalents	1.93B
Total Debt	158.46M
Net Cash	1.77B
Net Cash Per Share	$9.17
Equity (Book Value)	1.60B
Book Value Per Share	8.42
Working Capital	1.73B

Cash Flow

In the last 12 months, operating cash flow was -$761.79 million and capital expenditures -$15.29 million, giving a free cash flow of -$777.08 million.

Operating Cash Flow	-761.79M
Capital Expenditures	-15.29M
Free Cash Flow	-777.08M
FCF Per Share	-$4.02

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.98%
Shareholder Yield	-15.98%
Earnings Yield	-6.51%
FCF Yield	-5.27%

Analyst Forecast

The average price target for RVMD is $77.11, which is 1.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$77.11
Price Target Difference	1.04%
Analyst Consensus	Strong Buy
Analyst Count	18
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-40.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1